IRCT20140802018655N6
Completed
Phase 2
The evaluation of therapeutic effect of dopamine agonist (bromocriptine) on endometrioma size
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A definitive diagnosis of endometrioma
Exclusion Criteria
- •patients with hyperprolactinemia
- •People with coagulation disorders
- •who have contraindications to medroxyprogesterone
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
The effect of dopamine on the appropriate time of urination in oliguric patientsoliguria.Anuria and oliguriaIRCT2017011513366N6Vice Chancellor for Research,Arak University of Medical Sciences120
Completed
Not Applicable
The role of dopamine for positive treatment expectations and placebo analgesiapain perceptionhealthy subjectsDRKS00029366Klinische Neurowissenschaften und translationale Schmerzforschung, Universitätsmedizin Essen, Klinik für Neurologie169
Completed
Phase 3
Randomised trial of dopamine vs dobutamine for treatment of low systemic blood flow in very preterm infantsow systemic blood flow in preterm infantsLow systemic blood flow in preterm infantsReproductive Health and Childbirth - Complications of newbornACTRN12607000152426A/Prof Nick Evans45
Completed
Phase 4
Pharmaceutical enhancement of complex problem-solving in healthy adultsCognitive enhancementMental Health - Studies of normal psychology, cognitive function and behaviourNeurological - Studies of the normal brain and nervous systemACTRN12617001544369The University of Melbourne32
Completed
Phase 1
Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's DiseaseParkinson's DiseaseNCT00666653Oregon Health and Science University13